| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AZD6482 | CTRPv2 | pan-cancer | AAC | 0.034 | 0.4 |
| mRNA | istradefylline | CTRPv2 | pan-cancer | AAC | -0.05 | 0.4 |
| mRNA | BRD-K88742110 | CTRPv2 | pan-cancer | AAC | -0.033 | 0.4 |
| mRNA | SR1001 | CTRPv2 | pan-cancer | AAC | -0.035 | 0.4 |
| mRNA | lomeguatrib | CTRPv2 | pan-cancer | AAC | 0.034 | 0.4 |
| mRNA | FSC231 | CTRPv2 | pan-cancer | AAC | -0.067 | 0.4 |
| mRNA | silmitasertib | CTRPv2 | pan-cancer | AAC | -0.035 | 0.4 |
| mRNA | CCT036477 | CTRPv2 | pan-cancer | AAC | -0.03 | 0.4 |
| mRNA | SNX-2112:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.029 | 0.4 |
| mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | 0.028 | 0.4 |